Common diabetes drug may 'revolutionize' cancer therapies

Researchers at McGill University and the University of Pennsylvania have discovered that a widely used anti-diabetic drug can boost the immune system and increase the potency of vaccines and cancer treatments. Their findings will be published June 3 in the journal Nature.

Read the whole article on Physorg

More from Physorg